南昌市各区县药物监管能力现状分析  

Analysis of the current status of drug regulatory capacity in various districts and counties of Nanchang City

作　　者：倪雯 Ni Wen(Market supervision and administration of law enforcement inspection bureau of Nanchang City,Nanchang,Jiangxi 330000,China)

机构地区：[1]南昌市市场监督管理执法稽查局,江西南昌330000

出　　处：《首都食品与医药》2025年第5期114-117,共4页Capital Food Medicine

摘　　要：目的 了解南昌市各区县药物监管机构的能力现状,分析药物监管能力建设的制约因素与需求,为制定相关政策提供依据.方法 收集南昌市辖区内药品监管系统相关数据,对药品监管机构药品监管人员构成及各区(县)药品监管能力现状等情况进行描述性分析.结果 南昌市药品监管系统从事药品监管的人员占在岗总人数的10%;每个区(县)药品监管机构从事药品监管工作的人员平均5.3人,从事药品监管工作年限平均4.7年,全市85.7%的区(县)药品监管机构有独立承担药品监管工作的科室;全市58.33%的区(县)药品监管机构制定了药品管理实施方案,42.9%的区(县)药品监管机构在本级政府财政预算中有药品监管专项经费;覆盖全市范围的药品安全监测仅有药品质量监测.结论 南昌市药品监管系统基础较好,但部分区(县)在政策制定和经费上不足,影响工作全面性.个体化干预覆盖率低,科研参与度低,未来需完善政策,加强高风险药品监管,提升科学性和有效性,保障公众用药安全.Objective To understand the current capacity of drug regulatory agencies in various districts and counties of Nanchang City,analyze the constraints and demands in drug regulatory capacity building,and provide a basis for formulating relevant policies.Methods Data related to the drug regulatory system in Nanchang City were collected,and descriptive analyses were conducted on the composition of personnel in drug regulatory agencies and the current status of drug regulatory capacity in each district(county).Results Personnel engaged in drug regulation constitute 10%of the total number of employees in the Nanchang drug regulatory system.Each district(county)has an average of 5.3 personnel involved in drug regulation,with an average work experience of 4.7 years.In 85.7%of districts(counties),drug regulatory agencies have dedicated departments responsible for drug regulation.Additionally,58.33%of these agencies have formulated and issued drug management implementation plans,and 42.9%have allocated special funds for drug regulation in their local government budgets.Drug safety monitoring across the city is limited to drug quality monitoring.Conclusion The drug regulatory system in Nanchang City has a solid foundation;however,some districts(counties)lack sufficient policy development and funding,which affects the comprehensiveness of their work.The coverage rate of individualized interventions and participation in scientific research is low.Future efforts should focus on improving policies,enhancing the regulation of high-risk drugs,and increasing scientific and effective measures to ensure public medication safety.

关 键 词：南昌市 药物监管 药物监测 现状分析 

分 类 号：R194[医药卫生—卫生事业管理]